Mark A. Little

10.5k citations

149 papers · 4.1k indexed · h-index 36

Impact in

Nephrology top 0.5%
- Renal Diseases and Glomerulopathies
Transplantation top 1%
- Renal Transplantation Outcomes and Treatments

Papers in

Nephrology 32
- Renal Diseases and Glomerulopathies 24
Transplantation 10

Co-authors: Peter J. Conlon Charles D. Pusey David Jayne Lorraine Harper Caroline O. S. Savage KS Pieper Daniel B. Mark J. Joseph Walshe
Journals: Lara D. Veeken (14 papers)Nephrology Dialysis Transplantation (11 papers)Renal Failure (7 papers)Transplantation (5 papers)Kidney International Reports (5 papers)
Partner nations: Ireland United Kingdom United States

In The Last Decade

Mark A. Little

139 papers receiving 4.0k citations

Peers

Countries citing papers authored by Mark A. Little

Since Specialization

Citations

This map shows the geographic impact of Mark A. Little's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Little with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Little more than expected).

Fields of papers citing papers by Mark A. Little

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Little. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Little. The network helps show where Mark A. Little may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mark A. Little, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark A. Little Line = papers co-authored together Mark A. Little links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Long-Term Follow-Up of a Glucocorticoid Minimizing Regimen for the Treatment of Severe Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis Kidney International Reports ·Stephen P. McAdoo, Ruth J. Pepper, Maria Prendecki, Fabiana Barbosa Gomes, ELINOR J. BURWELL, Áine Burns, Marie Condon, Sally Hamour, Megan Griffith, Jeremy Levy, Tom Cairns, Mark A. Little, Alan D. Salama, Charles D. Pusey	2025	0
2	Data-driven subclassification of ANCA-associated vasculitis: model-based clustering of a federated international cohort The Lancet Rheumatology ·George ThomasKurian, Arthur White, Louis J. M. Aslett, Zdenka Hrušková, Peter Lamprecht, Jacek Musiał, K-M Sim, AndrÃƒÂ© Paviotti Fontana, Declan O’Sullivan, Xavier Puéchal, G. Petrovica, Mårten Segelmark, Benjamin Terrier, Vladimı́r Tesař, M. Gilbert, Augusto Vaglio, Krzysztof Wójcik, Mark A. Little, Aladdin J Mohammad, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2024	8
3	Computable phenotype for real-world, data-driven retrospective identification of relapse in ANCA-associated vasculitis RMD Open ·Jennifer Scott, Arthur White, Cathal Walsh, Louis J. M. Aslett, Matthew A. Rutherford, James Ng, Conor Judge, 宋江华, P. Leßmann, John D. Kelleher, 鲍钰清, Niall Conlon, Sarah Moran, Raashid Luqmani, Peter A. Merkel, Vladimı́r Tesař, Zdenka Hrušková, Mark A. Little	2024	0
4	Autoantibodies towards HFE and SYT5 in anti-neutrophil cytoplasm antibody-associated vasculitis relapse Lara D. Veeken ·Shaghayegh Bayati, A. Kh. Dusmatov, James Ng, N. Bhashar Reddy, 厚志西下, Mark A. Little, Peter Nilsson, Elisa Pin	2024	0
5	Lin⁻CD117⁺CD34⁺FcεRI⁺ progenitor cells are increased in chronic spontaneous urticaria and predict clinical responsiveness to anti‐IgE therapy Allergy ·Katie Ridge, Barry Moran, Abigail Alvarado-Vázquez, Jenny Hallgren, Mark A. Little, Alan D. Irvine, Cliona O’Farrelly, Jean Dunne, Conor M. Finlay, Judith Herrmann	2024	4
6	Emergence of dysfunctional neutrophils with a defect in arginase-1 release in severe COVID-19 JCI Insight ·A. Lawrence Greil, Peter S Skinner, M. P. Carroll, Hassan Alhamoudi, Isabella Batten, 岡田宣久, 郑泽俊, W. Stortenbeker, N. Bhashar Reddy, Mônica Turchetto, es Keiler Arnaldo González Torres, Padraic G. Fallon, فؤاد عزوز, J A Hoffman, Niall Conlon, Clíona Ní Cheallaigh, Conor M. Finlay, Mark A. Little	2024	4
7	The effects of plasma exchange and glucocorticoids on early kidney function among patients with ANCA-associated vasculitis in the PEXIVAS trial Kidney International ·Balazs Odler, Regina Riedl, Duvuru Geetha, Wladimir Szpirt, Carmel M. Hawley, S. Symeonidis, Zachary S. Wallace, Giles Walters, Fidelis Mukudi, Vladimı́r Tesař, Charles D. Pusey, Mark A. Little, Peter A. Merkel, Michael Walsh, David Jayne, Andreas Kronbichler, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2024	3
8	FTY720 ameliorates experimental MPO-ANCA-associated vasculitis by regulating fatty acid oxidation via the neutrophil PPARα–CPT1a pathway Lara D. Veeken ·Wei Zhou, Mateo Alejandro Rivas Pinzón, Xiangyu Han, Sufang Chen, Xiaojing Sun, Zhiying Li, Mark A. Little, Ming‐Hui Zhao, Min Chen	2024	6
9	#4553 REAL WORLD DATA-DRIVEN IDENTIFICATION OF ANCA VASCULITIS RELAPSE Nephrology Dialysis Transplantation ·Jennifer Scott, Arthur White, Cathal Walsh, Louis J. M. Aslett, Aifeng Pan, James Ng, Conor Judge, 宋江华, John D. Kelleher, 鲍钰清, Niall Conlon, Sarah Moran, Raashid Luqmani, Peter A. Merkel, Vladimı́r Tesař, Zdenka Hrušková, Mark A. Little	2023	1
10	Extended data for 'ANCA-associated vasculitis in Ireland: a multi-centre national cohort study' Zenodo (CERN European Organization for Nuclear Research) ·Noah Vickery, Hyeonseok Ko, Nicole Steen, Rosa V. González Zúñiga, Yunisurika, Brigitte Grewe, Arthur White, Cathal Walsh, Louis J. M. Aslett, Andreas Villar, Michael R. Clarkson, John Holian, Matthew D. Griffin, Niall Conlon, Yvonne O’Meara, Liam Casserly, Eamonn Molloy, 鲍钰清, Sarah Moran, Mark A. Little	2022	0
11	Inhibitor of apoptosis proteins antagonist SM164 ameliorates experimental MPO-ANCA-associated vasculitis via enhancing fatty acid oxidation in neutrophils Lara D. Veeken ·Mateo Alejandro Rivas Pinzón, Ruixue Wang, Chen Wang, Sufang Chen, Xiaojing Sun, Zhiying Li, Min Chen, Mark A. Little, Ming‐Hui Zhao	2022	8
12	Acute renal allograft failure in a patient with vasculitis Lara D. Veeken ·Rosa V. González Zúñiga, Jennifer Scott, Anthony Dorman, Mark A. Little, D.G. de Freitas	2021	0
13	Dynamic Assay for Profiling Anti-SARS-CoV-2 Antibodies and Their ACE2/Spike RBD Neutralization Capacity Viruses ·Thomas Phelan, Jean Dunne, Niall Conlon, Clíona Ní Cheallaigh, W. Mark Abbott, 直樹石松, Fatima Amanat, Florian Krammer, Mark A. Little, Gerard Hughes, Colm Bergin, Colm Kerr, Margaret R Flannery, Aideen Long, William McCormack, Gareth Brady	2021	11
14	The Clinical Application of Urine Soluble CD163 in ANCA-Associated Vasculitis Journal of the American Society of Nephrology ·Sarah Moran, Jennifer Scott, Michael R. Clarkson, Niall Conlon, Jean Dunne, Matthew D. Griffin, Tomás P. Griffin, Elisa Ferrari, John Holian, Conor Judge, Jason Wyse, Berend Koene, Paul O’Hara, H. Y. Hsun, Mark A. Little, (unknown)	2021	25
15	SAT0578 TOWARDS EUROPEAN HARMONISATION OF HEALT CARE FOR PATIENTS WITH RARE IMMUNE DISORDERS: ERN RITA RESULT FROM THE REGISTRIES SURVEY Annals of the Rheumatic Diseases ·Riccardo Papa, Andrew J. Cant, Christoph Klein, Mark A. Little, Nico Wulffraat, Marco Gattorno, Nicolino Ruperto	2019	0
16	A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody–associated vasculitis Lara D. Veeken ·Ruth J. Pepper, Stephen P. McAdoo, Sarah Moran, Dearbhla Kelly, Jennifer Scott, Sally Hamour, Áine Burns, Megan Griffith, Jack Galliford, Jeremy Levy, Thomas Cairns, Seerapani Gopaluni, Rachel Jones, David Jayne, Mark A. Little, Charles D. Pusey, Alan D. Salama	2018	58
17	Determinants of Poor Quality of Life in ANCA Associated Vasculitis (AAV). Oxford University Research Archive (ORA) (University of Oxford) ·Neil Basu, Andrew McClean, Raashid Luqmani, Lorraine Harper, Oliver Floßmann, David Jayne, Mark A. Little, E. Nicole Amft, Neeraj Dhaun, Soumeya Aliouane, Veena Kumar, Lars P. Erwig, Gregory T. Jones, H. trialists, Gary J. Macfarlane	2012	1
18	Mortality prediction after kidney transplantation: comparative clinical use of 7 comorbidity indices. PubMed ·Jason H. Moore, Xiang He, Xiang Liu, Shazia Shabir, Simon Ball, Paul Cockwell, Nicholas Inston, Mark A. Little, A. E. Johnston, Richard Borrows	2011	21
19	MEASUREMENT OF DAMAGE IN SYSTEMIC VASCULITIS: A COMPARISON OF THE VASCULITIS DAMAGE INDEX (VDI) WITH THE COMBINED DAMAGE ASSESSMENT INDEX (CDA) Oxford University Research Archive (ORA) (University of Oxford) ·Ravi Suppiah, Ekta Chaudhary, Chetan Mukhtyar, Federico Alberici, Bo Baslund, Denise Scott Brown, Daniela Albornoz Jaramillo, Julia U. Holle, Zdenka Hrušková, David Jayne, Andrew Judge, Mark A. Little, Peter A. Merkel, Alessandra Palmisano, Philip Seo, Coen A. Stegeman, Vladimı́r Tesař, Augusto Vaglio, Kerstin Westman, Raashid Luqmani	2010	4
20	Rapidly progressive glomerulonephritis: Current and evolving treatment strategies Journal of Nephrology ·Mark A. Little, Charles D. Pusey	2004	23

About Mark A. Little

Mark A. Little is a scholar working on Nephrology, Transplantation, Genetics, Pulmonary and Respiratory Medicine and Rheumatology, having authored 149 papers that have together received 4.1k indexed citations. Recurring topics across this work include Vasculitis and related conditions (78 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (28 papers), Renal Diseases and Glomerulopathies (24 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (16 papers), Otitis Media and Relapsing Polychondritis (16 papers), Sarcoidosis and Beryllium Toxicity Research (13 papers), Urticaria and Related Conditions (12 papers) and Cell Adhesion Molecules Research (11 papers). The work is most often cited by research in Nephrology (987 citations), Transplantation (284 citations), Pulmonary and Respiratory Medicine (2.4k citations), Genetics (734 citations) and Immunology (1.1k citations). Mark A. Little has collaborated with scholars based in Ireland, United Kingdom and United States. Frequent co-authors include Peter J. Conlon, Charles D. Pusey, David Jayne, Lorraine Harper, Caroline O. S. Savage, KS Pieper, Daniel B. Mark, J. Joseph Walshe, Alan D. Salama and Sussan Nourshargh. Their work appears in journals such as Lara D. Veeken, Nephrology Dialysis Transplantation, Renal Failure, Transplantation and Kidney International Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact